coated aspirin

Generic: aspirin

Labeler: l.n.k. international, inc.
NDC Directory HUMAN OTC DRUG OTC MONOGRAPH DRUG Inactive Finished

Drug Facts

Product Profile

Brand Name coated aspirin
Generic Name aspirin
Labeler l.n.k. international, inc.
Dosage Form TABLET, FILM COATED
Routes
ORAL
Active Ingredients

aspirin 325 mg/1

Manufacturer
L.N.K. International, Inc.

Identifiers & Regulatory

Product NDC 50844-254
Product ID 50844-254_17cb371b-3373-42aa-9706-f9e843474537
Product Type HUMAN OTC DRUG
Marketing Category OTC MONOGRAPH DRUG
Application Number M013
Marketing Start 2019-07-15
Marketing End 2026-10-31

Pharmacologic Class

Established (EPC)
nonsteroidal anti-inflammatory drug [epc] platelet aggregation inhibitor [epc]
Mechanism of Action
cyclooxygenase inhibitors [moa]
Chemical Structure
anti-inflammatory agents, non-steroidal [cs]
Physiologic Effect
decreased prostaglandin production [pe] decreased platelet aggregation [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 50844254
Hyphenated Format 50844-254

Supplemental Identifiers

RxCUI
212033
UPC
0052548689964
UNII
R16CO5Y76E
NUI
N0000000160 N0000008836 M0001335 N0000175722 N0000175578 N0000008832

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name coated aspirin (source: ndc)
Generic Name aspirin (source: ndc)
Application Number M013 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 325 mg/1
source: ndc
Packaging
  • 1 BOTTLE, PLASTIC in 1 CARTON (50844-254-12) / 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC
source: ndc

Packages (1)

Ingredients (1)

aspirin (325 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "17cb371b-3373-42aa-9706-f9e843474537", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832"], "upc": ["0052548689964"], "unii": ["R16CO5Y76E"], "rxcui": ["212033"], "spl_set_id": ["e077fe14-62bb-462b-bfa3-8a83c06c22f1"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["L.N.K. International, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, PLASTIC in 1 CARTON (50844-254-12)  / 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC", "package_ndc": "50844-254-12", "marketing_end_date": "20261031", "marketing_start_date": "20190715"}], "brand_name": "Coated Aspirin", "product_id": "50844-254_17cb371b-3373-42aa-9706-f9e843474537", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "product_ndc": "50844-254", "generic_name": "Aspirin", "labeler_name": "L.N.K. International, Inc.", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Coated Aspirin", "active_ingredients": [{"name": "ASPIRIN", "strength": "325 mg/1"}], "application_number": "M013", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_end_date": "20261031", "marketing_start_date": "20190715"}